Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 2;11(1):13781.
doi: 10.1038/s41598-021-93275-9.

Prognostic factors of restrictive myopathy in thyroid eye disease

Affiliations

Prognostic factors of restrictive myopathy in thyroid eye disease

Jae Hwan Choi et al. Sci Rep. .

Abstract

To investigate the prognostic factors of extraocular muscle restriction in patients with thyroid eye disease (TED), 65 patients with TED and restrictive myopathy were evaluated. Demographics, clinical activity score (CAS), smoking status, thyroid disease status, thyroid hormone status, thyroid autoantibody status, orbital computed tomography (CT) scan at initial presentation, and treatment regimens were assessed. The movements of the most severely affected extraocular muscles were categorized into five grades. The patients were divided into the improved and the not-improved group based on the improvement in the limitation of the extraocular muscle excursion (LOM) throughout the follow-up, and the groups were compared using clinical factors. The mean LOM significantly improved from 2.3 ± 1.1 to 1.7 ± 1.2 after 1 year of follow-up. The excursion of the most restricted muscle improved in 32 patients but not in 33 patients during the follow-up. The initial concentration of the thyroid-stimulating antibody (TSAb) was significantly lower in the improved (229.3 ± 114.1) than in the not-improved group (345.0 ± 178.6) (P = 0.02) Age, sex, smoking status, CAS, thyroid status, and muscle thickness on the CT scan did not significantly differ in the groups. This study showed that the initial concentration of TSAb is a factor affecting the recovery of restrictive myopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Shan SJ, Douglas RS. The pathophysiology of thyroid eye disease. J. Neuroophthalmol. 2014;34:177–185. doi: 10.1097/WNO.0000000000000132. - DOI - PubMed
    1. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 2003;163:1291–1300. doi: 10.1016/s0002-9440(10)63488-8. - DOI - PMC - PubMed
    1. Kumar S, Iyer S, Bauer H, Coenen M, Bahn RS. A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: Inhibition by an IGF-I receptor blocking antibody. J. Clin. Endocrinol. Metab. 2012;97:1681–1687. doi: 10.1210/jc.2011-2890. - DOI - PMC - PubMed
    1. Aniszewski JP, Valyasevi RW, Bahn RS. Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 2000;85:776–780. doi: 10.1210/jcem.85.2.6333. - DOI - PubMed
    1. Romagnani S, et al. An update on human Th1 and Th2 cells. Int. Arch. Allergy Immunol. 1997;113:153–156. doi: 10.1159/000237532. - DOI - PubMed

MeSH terms

Substances